Impact of TLR2 Stimulation on Neonatal Mouse Brain Development
Author Information
Author(s): Du Xiaonan, Fleiss Bobbi, Li Hongfu, D'angelo Barbara, Sun Yanyan, Zhu Changlian, Hagberg Henrik, Levy Ofer, Mallard Carina, Wang Xiaoyang
Primary Institution: University of Gothenburg
Hypothesis
Stimulation of TLR2 during a critical period of neonatal brain development would have a detrimental effect on the immature brain.
Conclusion
Repeated systemic exposure to the TLR2 agonist Pam3CSK4 can have a short-term negative impact on the neonatal mouse brain.
Supporting Evidence
- Pam3CSK4 administration led to decreased brain weight and increased spleen and liver weights.
- Significantly elevated levels of inflammatory cytokines were detected after Pam3CSK4 treatment.
- Pam3CSK4-treated mice showed decreased neuronal density in the hippocampus.
- Long-term memory function was not affected by Pam3CSK4 administration.
Takeaway
Giving a special substance to baby mice can hurt their brains for a little while, but they seem to get better as they grow up.
Methodology
Mice were injected with a TLR2 agonist or control substances, and their brain, spleen, and liver were analyzed for weight and injury markers.
Potential Biases
Potential bias in the interpretation of results due to the specific focus on TLR2 without considering other factors.
Limitations
The study primarily focused on short-term effects and did not explore potential long-term impacts beyond the observed recovery.
Participant Demographics
Neonatal mice of both genders were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website